Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin

International Journal of Radiation Oncology, Biology, Physics

Volumn 20, Issue 2, 1991, Pages 221-225

  Skov, Kirsten ^a   Macphail, Susan ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Carboplatin; Cisplatin; Hypoxia; Interaction; Iproplatin; Irradiation; Low doses; Sensitization; Tetraplatin; V79 cells

Indexed keywords

CARBOPLATIN; CISPLATIN; IPROPLATIN; TETRAPLATIN;

ANIMAL CELL; CELL STRAIN V 79; CONFERENCE PAPER; CONTROLLED STUDY; DRUG THERAPY; HAMSTER; HYPOXIA; PRIORITY JOURNAL; RADIOSENSITIZATION; RADIOTHERAPY; X IRRADIATION;

ANIMAL; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; HAMSTERS; ORGANOPLATINUM COMPOUNDS; RADIATION TOLERANCE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025981036     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(91)90094-K     Document Type: Article

References (20)

1. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-Diaminocyclohexane
2. Clinical trials of radiosensitizers: what should we expect?
3. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin
4. Combined treatment of radiation and cis-diamminedichloroplatinum(II): a review of experimental and clinical data
5. Keynote address: platinum-radiation interactions
6. Carboplatin as a potentiator of radiation therapy
7. Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes
8. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-Diamminedichloroplatinum and cis-Diammine(1,1-cyclobutanedicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA
9. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses
10. Radiation and platinum drug interaction
11. Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells
12. Survival measurements at low doses: oxygen enhancement ratio
13. The effect of misonidazole as a hypoxic radiosensitizer at low doses
14. The use of solid-state image sensor technology to detect and characterize live mammalian cells grown in tissue culture
15. Reduced oxygen enhancement ratio at low doses of ionizing radiation
16. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA
17. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)l,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue
18. Radiosensitization of hypoxic cells at low doses
19. 2) with low doses of radiation in mammalian cells
20. Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low X ray doses